AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2017
Apr 3, 2017
34395_dirs_2017-04-03_650d1f54-7ade-441c-8441-29c88f7cd4f5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2017-03-30
Reporting Person: Innes Guy Archibald (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-03-30 | Stock Option (Right to Buy) | $5 | A | 20000 | Acquired | 2023-03-30 | Common Stock (20000) | Direct |
Footnotes
F1: A total of 20,000 Options were granted on March 30, 2017 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant.
More from VOLITIONRX LTD
Capital/Financing Update
2026
Jun 9
Capital/Financing Update
2026
Jun 9
Capital/Financing Update
2026
Jun 5
Proxy Solicitation & Information Statement
2026
Jun 2
Capital/Financing Update
2026
May 22
Board/Management Information
2026
May 15
Interim / Quarterly Report
2026
May 14
Report Publication Announcement
2026
May 14
Proxy Solicitation & Information Statement
2026
May 13
Annual Report
2026
Apr 30